
Bartu Ahiska
@drbartu
Business builder, entrepreneur, commercial strategist & tech driver with 20 patent filings in MedTech, Dx, AI/cloud. Senior Dir. at OBD. Views are my own.
ID: 857249324
http://uk.linkedin.com/in/bartuahiska 02-10-2012 00:32:26
161 Tweet
353 Followers
217 Following

Daily Express spotlights the presentation in Parliament of Oxford BioDynamics’ EpiSwitch PSE test for accurately detecting #prostatecancer. ProstateCancerResearch Landmark Report on prostate screening highlighted #PSE as an opportunity to improve diagnosis express.co.uk/news/uk/199165… 94percent.com

📢 BREAKING: 1 in 8 UK men will face prostate cancer. Former Prime Minister Rishi Sunak joins ProstateCancerResearch as ambassador to push for national screening using revolutionary EpiSwitch PSE test (94% accuracy!). urologynews.uk.com/news/post/rish… #urologynews #MensHealth #CancerScreening

Where can you get tested for #ProstateCancer with the highly accurate #EpiSwitchPSE? The PSE is now available at 150 Goodbody Clinic sites across the UK. Find your nearest clinic at mypse.co/Goodbody. Brought to you by Oxford BioDynamics and Goodbody Clinic. #TalkToYourDoctor



I attended the All-Party Parliamentary Group on #ProstateCancer UK House of Commons, which focused on real-world evidence addressing concerns over risks of overdiagnosis & overtreatment. Thanks ProstateCancerResearch Prostate Cancer UK Calvin Bailey MBE MP MP for making it happen. Oxford BioDynamics 94percent.com


🧬 Good to see Oxford BioDynamics’ EpiSwitch #PSE test featured again in The The Telegraph today, highlighting the role that the blood test's accuracy is playing in detecting #ProstateCancer. Read the full article here: telegraph.co.uk/health-fitness… #OBD #MensHealth 94percent.com


#OBD Oxford BioDynamics’ #EpiSwitchPSE test for #ProstateCancer is now offered at The London GP TLGP—Harley Street’s private GP serving 10,000 patients. We continue to grow our provider network. 🔗Visit mypse.co/tlgp. HCA Healthcare HCA Healthcare UK 94percent.com

📣 I am looking forward to sitting down with the Urology News editor at the #BAUS25 Annual Scientific Meeting in #Manchester (16 June) to update readers on #OBD progress with the #EpiSwitchPSE #ProstateCancer blood test. Please message me to meet at BAUS. BAUS Oxford BioDynamics

The The Telegraph highlights #EpiSwitchPSE as a next-gen test reducing false positives in #ProstateCancer testing. Better testing ➡️ earlier diagnosis ➡️ better outcomes. 📖 Read more: mypse.co/ld8. #EarlyDetectionSavesLives

#OBD Oxford BioDynamics Interview with Senior Commercial Director ‘This company has unlocked 3G Genomics in a way that multi-billion dollar pharma in the US have just not managed to do’ #episwitch #prostatecancer #biotech #pharma youtu.be/EGh1-fEaiso?si…

🩺 June is #MensHealthMonth—there’s no better time to talk #Cancer #EarlyDetection. Join Oxford BioDynamics (#OBD) as we kick off the month with advocate alfredsamuels, who shares his deeply personal #ProstateCancer story. Learn how the #EpiSwitchPSE test can help you 94percent.com

✔️Day 1 of #BAUS25 complete. Thank you #UrologyNews team for sharing this about Oxford BioDynamics' (#OBD) #EpiSwitchPSE #prostatecancer detection blood test today at the BAUS annual meeting. Urology News TheUrologyFoundation


🎙️Insightful #ProstateCancer testing primer—including a discussion of Oxford BioDynamics' #EpiSwitchPSE at ~12min—from Tim Woodman, Bupa Medical Director, and Richard, reflecting on his cancer. The #OBD #PSE blood test (94percent.com) is available under Bupa youtube.com/watch?si=w-e_w…

📰“A British-made #ProstateCancer test could remove the need for biopsies in 4 out of 5 cases” —Daily Mail covers an Oxford BioDynamics study showing compelling evidence from a US #urology clinic on #EpiSwitchPSE’s real-world impact. obdx.co/dm2 MDPI #OBD


Thank you to Alex Schlich and Killik & Co for hosting us at your Summer Event. It was a pleasure to represent Oxford BioDynamics (#OBD), showcase our leading #EpiSwitchPSE #ProstateCancer test, and raise funds for Prostate Cancer Research ProstateCancerResearch. 94percent.com


🌐🧬 Oxford BioDynamics is collaborating with Google Cloud to support the development and deployment of #OBD’s cutting-edge analytical framework on the cloud. Read more👇 obdx.co/ggl #PrecisionMedicine #AI #HealthcareInnovation #EpiSwitch #Genomics Google
